SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-11-055627
Filing Date
2011-11-09
Accepted
2011-11-09 17:45:01
Documents
1
Period of Report
2011-11-01

Document Format Files

Seq Description Document Type Size
1 F3 PHILLIPS rrd325288.html 3  
1 F3 PHILLIPS rrd325288.xml 3 1538
  Complete submission text file 0001181431-11-055627.txt   3040
Mailing Address 10940 WILSHIRE BLVD. SUITE 600 LOS ANGELES CA 90024
Business Address 10940 WILSHIRE BLVD. SUITE 600 LOS ANGELES CA 90024 (310) 443-4150
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10990 WILSHIRE BOULEVARD SUITE 1200 LOS ANGELES MN 90024
Business Address
PHILLIPS RICHARD BENTON (Reporting) CIK: 0001433384 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52811 | Film No.: 111192730